Expanded dengue syndrome: subacute thyroiditis and intracerebral hemorrhage

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Assir, Muhammad Zaman K ^a   Jawa, Ali ^b   Ahmed, Hafiz I ^b  

^a JINNAH HOSPITAL   (Pakistan)

^b ALLAMA IQBAL MEDICAL COLLEGE   (Pakistan)

Author keywords

Dengue fever; Expanded dengue syndrome; Intracerebral Hemorrhage; Thyroiditis

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; LIOTHYRONINE; MANNITOL; PARACETAMOL; PREDNISOLONE; PROPRANOLOL; TECHNETIUM; THYROTROPIN; THYROXINE; TRACER;

ADULT; ARTHRALGIA; ARTICLE; BALNEOTHERAPY; BODY POSITION; BRAIN HEMORRHAGE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DENGUE; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; EXPANDED DENGUE SYNDROME; FEVER; FOLLOW UP; FREE LIOTHYRONINE INDEX; FRONTAL LOBE; GINGIVA BLEEDING; HEAD ELEVATION; HEADACHE; HEART PALPITATION; HEMATOCRIT; HEMATOMA; HOARSENESS; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; INTRACRANIAL PRESSURE; LEUKOPENIA; MALE; MYALGIA; NECK PAIN; ODYNOPHAGIA; ORBIT INJURY; PAKISTAN; RETROORBITAL PAIN; SPONGING; SUBACUTE THYROIDITIS; SYMPTOMATOLOGY; THROMBOCYTOPENIA; THYROID SCINTISCANNING; THYROIDITIS; TREATMENT OUTCOME; TREMOR; UNCONSCIOUSNESS; VOMITING;

BRAIN; CEREBRAL HEMORRHAGE; DENGUE HEMORRHAGIC FEVER; HUMANS; MALE; PAKISTAN; THYROIDITIS, SUBACUTE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84866874937     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-240     Document Type: Article

References (10)

1. WHO. Dengue hemorrhagic fever diagnosis, treatment, prevention, and control 1997, World Health Organization, Geneva, 2, WHO. Dengue hemorrhagic fever.
2. WHO: Dengue Guidelines for diagnosis, treatment, prevention and control 2009, World Health Organization, Geneva, New edition, WHO: Dengue.
3. WHO Comprehensive guidelines for prevention and control of dengue and dengue hemorrhagic fever 2011, World Health Organization, Regional Office for South-East Asia, Revised and expanded edition http://www.searo.who.int/LinkFiles/Dengue_DHF_prevention&control_guidelines_rev.pdf, WHO.
4. Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet 2000, 355(9209):1053-1059. 10.1016/S0140-6736(00)02036-5, 10744091.
5. Wani AM, Mejally MA, Hussain WM, et al. Skin rash, headache and abnormal behaviour: unusual presentation of intracranial haemorrhage in dengue fever. BMJ Case Rep 2010, 2010. Epub 2010 Jan 13.
6. Kumar V, Kataria R, Mehta VS. Dengue hemorrhagic fever: a rare cause of pituitary tumor hemorrhage and reversible vision loss. Indian J Ophthalmol 2011, 59(4):311-312. 10.4103/0301-4738.82002, 3129759, 21666319.
7. Wildemberg LE, Neto LV, Niemeyer P, et al. Dengue hemorrhagic fever: a condition associated with multiple risk factors for pituitary apoplexy. Endocr Pract 2012, 31:1-17.
8. Lazarus JH. Silent thyroiditis and subacute thyroiditis. The Thyroid: A Fundamental and Clinical Text 1996, 577. Lippincott Williams & Wilkins, Philadelphia, Braverman LE, Utiger RD, 7.
9. Nishihara E, Ohye H, Amino N, et al. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med 2008, 47:725. 10.2169/internalmedicine.47.0740, 18421188.
10. Yamamoto M, Saito S, Sakurada T, et al. Effect of prednisolone and salicylate on serum thyroglobulin level in patients with subacute thyroiditis. Clin Endocrinol (Oxf) 1987, 27:339.